MicroTransponder
TX - AustinBiotechnology
Focus: MicroTransponder is a publicly traded medical device company specializing in vagus nerve stimulation (VNS) technology for neurological and cardiovascular indications. The company is focused on a single therapeutic platform applied across stroke, spinal cord injury, and tinnitus indications.
Profile data last refreshed Yesterday · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
0
About MicroTransponder
AI assessmentNot HiringNo open roles listed right now. Follow MicroTransponder to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
8 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Vivistim System
Growing
Growth
Lead commercial product addressing post-stroke motor recovery; primary driver of near-term revenue and clinical proof-of-concept for platform expansion.
Pipeline & Clinical Trials
Help build intelligence for MicroTransponder
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.